» Articles » PMID: 15130030

Validation of the Restless Legs Syndrome Quality of Life Instrument (RLS-QLI): Findings of a Consortium of National Experts and the RLS Foundation

Overview
Journal Qual Life Res
Date 2004 May 8
PMID 15130030
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: This study was designed to assess the initial psychometric properties of a new disease-specific health-related quality of life (HRQL) measure, the Restless Legs Syndrome (RLS) Quality of Life Instrument (RLS-QLI).

Methods: Draft items were generated from a literature review, consultation with MD and PhD specialists in the fields of neurology and sleep medicine, and input from two patient focus groups. The initial item reduction was accomplished using a survey of 392 persons with self-reported RLS symptoms from the membership of the RLS Foundation. The final (independent) validation sample consisted of 574 of persons on the RLS Foundation's Interest Group List Serve who also reported having RLS. The mean age of participants was 54.5 (SD 12.3), with a sex ratio of 1M:2F, and the majority was on some form of medication for RLS (66%).

Results: Four factors were identified (Daily Function, Social Function, Sleep Quality, and Emotional Well-Being) consisting of 17 items that explained 73.3% of the total variance. Each scale had good internal consistency (Cronbach's alpha's between 0.85 and 0.91) and 2-week test retest stability (Pearson Correlations between 0.81 and 0.93). Convergent validity was demonstrated using related scales on the SF-36 (r = 0.47-0.60) and criterion-related validity was shown using the clinical IRLS Scale of Symptom Severity (r = -0.45 to -0.77).

Conclusion: The RLS-QLI is a valid disease-specific HRQL instrument that will contribute to our understanding of how RLS impacts the lives of those affected with this CNS disorder.

Citing Articles

Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment.

Winkelman J, Berkowski J, DelRosso L, Koo B, Scharf M, Sharon D J Clin Sleep Med. 2024; 21(1):153-199.

PMID: 39324664 PMC: 11701280. DOI: 10.5664/jcsm.11392.


Restless legs syndrome.

Manconi M, Garcia-Borreguero D, Schormair B, Videnovic A, Berger K, Ferri R Nat Rev Dis Primers. 2021; 7(1):80.

PMID: 34732752 DOI: 10.1038/s41572-021-00311-z.


Aromatherapy Massage vs. Foot Reflexology on the Severity of Restless Legs Syndrome in Female Patients Undergoing Hemodialysis.

Ghasemi M, Rejeh N, Bahrami T, Heravi-Karimooi M, Tadrisi S, Vaismoradi M Geriatrics (Basel). 2021; 6(4).

PMID: 34698176 PMC: 8544351. DOI: 10.3390/geriatrics6040099.


Large genome-wide association study identifies three novel risk variants for restless legs syndrome.

Didriksen M, Nawaz M, Dowsett J, Bell S, Erikstrup C, Pedersen O Commun Biol. 2020; 3(1):703.

PMID: 33239738 PMC: 7689502. DOI: 10.1038/s42003-020-01430-1.


Tools for the Assessment of Pediatric Restless Legs Syndrome.

Stubbs P, Walters A Front Psychiatry. 2020; 11:356.

PMID: 32431628 PMC: 7214695. DOI: 10.3389/fpsyt.2020.00356.


References
1.
Guyatt G, Feeny D, Patrick D . Measuring health-related quality of life. Ann Intern Med. 1993; 118(8):622-9. DOI: 10.7326/0003-4819-118-8-199304150-00009. View

2.
Phillips B, Young T, Finn L, Asher K, Hening W, PURVIS C . Epidemiology of restless legs symptoms in adults. Arch Intern Med. 2000; 160(14):2137-41. DOI: 10.1001/archinte.160.14.2137. View

3.
Ulfberg J, Nystrom B, Carter N, Edling C . Restless Legs Syndrome among working-aged women. Eur Neurol. 2001; 46(1):17-9. DOI: 10.1159/000050750. View

4.
Trenkwalder C, Stiasny K, Pollmacher T, Wetter T, Schwarz J, Kohnen R . L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial. Sleep. 1995; 18(8):681-8. DOI: 10.1093/sleep/18.8.681. View

5.
Allen R, Earley C . Validation of the Johns Hopkins restless legs severity scale. Sleep Med. 2001; 2(3):239-242. DOI: 10.1016/s1389-9457(00)00080-0. View